Eli Lilly to Establish Global Capability Center in Hyderabad

US pharmaceutical giant Eli Lilly and Company announced that it intends to set up a new global capability center in Hyderabad. The organization plans to hire over 1,000 to 1,500 highly skilled individuals, including technology engineers and data...

Standardizing Medicine Labeling and Embracing Digital Transformation

Helen Critchley, Country Regulatory Head – Australia & NZ, Sanofi, at a session of the Asia Regulatory Conference, shared the importance of universal labeling and e-labeling in promoting digital transformation and global harmonization...

Novo Nordisk and Valo Health Partner to develop novel Treatments

Novo Nordisk A/S and Valo Health, Inc. announced they have established a broader agreement to research and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease, utilizing Valo’s vast human dataset and AI-driven...

Vividion Therapeutics Acquires Tavros Therapeutics

Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical firm leveraging innovative discovery technologies to reveal high-value, traditionally undruggable targets and create small molecule precision therapeutics for severe cancers and...

Zydus Partners with CVS Caremark to Expand Access to Diabetes Treatments

Zydus Lifesciences Ltd announced that it has formed a partnership with CVS Caremark to include Zituvio, Zituvimet, and Zituvimet XR tablets, which are utilized for diabetes treatment, in the latter's standard formulary. Zydus Lifesciences Ltd...

CHOP and UPenn Develop ATLAS-seq for Enhanced Cancer Immunity Detection

Researchers at the Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (UPenn) created a novel screening method, Aptamer-based T Lymphocyte Activity Screening and SEQuencing (ATLAS-seq)...

Cipla Launches Mobile App for Asthma Screening in India

Pharmaceutical company Cipla announced the rollout of a mobile app aimed at facilitating the initial screening for asthma in India. The Global Burden of Disease report estimates that asthma's total burden in India is roughly 34.3 million...

Bayer Bolsters India Focus with Expanded Therapies and Healthcare Ecosystem

German multinational pharmaceutical and biotechnology firm Bayer aims to bolster its presence in India by broadening its range of therapies and increasing collaborations throughout the healthcare ecosystem. Bayer has launched various treatments to...

Gene-Editing Tops Priority for 54% of Biotech Labs

According to recent data, 54% of advanced biotech laboratories have identified gene-editing research as their main growth engine this year, highlighting the increasing importance of this sector. The worldwide gene therapy market had a valuation of...

Impact of Modern Technology on the Indian Life Sciences Sector

AI and Machine Learning (ML) are at the forefront of revolutionizing the Indian life sciences sector, particularly in drug discovery and digital health...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.